Search Results
96 items found for "Roger Mills"
- 📰 GPCR Weekly News
Therapeutics strengthens Scientific Advisory Board with appointment of immuno-oncology experts More millions
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
Chemical libraries containing fragment- (1.6 million molecules) and lead-like (4.6 million molecules)
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
Chemical libraries containing fragment- (1.6 million molecules) and lead-like (4.6 million molecules)
- Functional Characterization of the Venus Flytrap Domain of the Human TAS1R2 Sweet Taste Receptor
This study demonstrates the feasibility of producing milligram quantities of hTAS1R2-VFT to further characterize
- Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline ...
molecule candidates across oncology and immunology Exscientia will receive an upfront cash payment of $100 million
- Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
License Agreement Neurocrine Biosciences has agreed to pay Sosei Heptares an upfront payment of US$100 million
- Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
decades—but the two-year-old biotech believes the area is still ripe for development, and it now has $100 million
- Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and...
., today announced it closed an oversubscribed $33 million financing round, extending its $100 million
- Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares
Cancer Research UK, a charity dedicated to funding lifesaving oncology research, spent £388 million on
- X4 slashes pipeline, lays off staff just three weeks after netting a $55M PIPE
The move comes less than three weeks after X4 pulled together a $55 million PIPE and amended a loan facility
- Third Rock pushes newest fund over $1B line as it marks 15 years in venture capital
2016, Abbie Celniker was promoted to partner at Third Rock Ventures as the firm raised just over $600 million
- Crinetics Pharmaceuticals Announces Pricing Of Underwritten Common Stock Offering
underwriting discounts and commissions and other offering expenses, are expected to be approximately $125.0 million